Pertuzumab Active Not Recruiting Phase 3 Trials for HER2/Neu Positive / Breast Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01996267Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2